Fierce Pharma: Reputation A Top Priority When Picking Prescription Meds

Prescription paper and pills | We. Communications

A Pharma company's reputation Ranked As A Leading Factor in Physician Prescription Decisions, According to We.'s Latest Healthy reputation: More Than Medicine Report

Fierce Pharma, Jacqueline Renfrow, 1 March 2023

In “Healthy Reputation: More Than Medicine,” healthcare professionals displayed their desire for pharma to go beyond just functional characteristics of a medication to address the entire health experience. In an interview with Fierce Pharma, Stephanie Marchesi, President, Global Health shared findings from We.'s latest report. 

“As communicators, our instincts and anecdotal feedback have told us that corporate reputation is important. But now we have hard evidence of its impact, both as influencing prescribing decisions among HCPs as well as contributing to the bottom line for biotech and pharma companies,” explained Marchesi.

To learn more, read We.'s latest Brands in Motion Report "Healthy Reputation: More Than Medicine."

 

   Full Article

 

(Photo courtesy of Fierce Pharma - Getty/LIgorko)

Explore more

scoot airplane | we. communications

Scoot Takes Flight With We. Communications

We. launches Reputation Forecast | We. Communications

We. Communications Launches Reputation Forecast: A Board-Level Framework for Managing Reputation Value and Risk

One person on a computer, working in a group of people

PRWeek: Budget Plan 2026—Balancing a Focus on AI with Human Connection

PRCA APAC executive panl of We. Future of Communications report

PRCA APAC Executive Briefing: The Future of Communications in Southeast Asia

Brian Keenan | We. Communications

Telum Media: Fortune Favours First-Movers Says Brian Keenan

"Provoke Media: 2025 Review" on geometric, blue background

PRovoke Media: 2025 Review—The Best Thought Leadership of the Past Year